IL164755A0 - Pharmaceutical composition containing a reversibleprotein pump inhibitor - Google Patents

Pharmaceutical composition containing a reversibleprotein pump inhibitor

Info

Publication number
IL164755A0
IL164755A0 IL16475504A IL16475504A IL164755A0 IL 164755 A0 IL164755 A0 IL 164755A0 IL 16475504 A IL16475504 A IL 16475504A IL 16475504 A IL16475504 A IL 16475504A IL 164755 A0 IL164755 A0 IL 164755A0
Authority
IL
Israel
Prior art keywords
reversibleprotein
pharmaceutical composition
composition containing
pump inhibitor
inhibitor
Prior art date
Application number
IL16475504A
Other languages
English (en)
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of IL164755A0 publication Critical patent/IL164755A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL16475504A 2002-05-07 2004-10-21 Pharmaceutical composition containing a reversibleprotein pump inhibitor IL164755A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02010305 2002-05-07
PCT/EP2003/004653 WO2003094967A2 (en) 2002-05-07 2003-05-03 New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders

Publications (1)

Publication Number Publication Date
IL164755A0 true IL164755A0 (en) 2005-12-18

Family

ID=29414673

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16475504A IL164755A0 (en) 2002-05-07 2004-10-21 Pharmaceutical composition containing a reversibleprotein pump inhibitor

Country Status (17)

Country Link
US (1) US20050222193A1 (no)
EP (1) EP1506016A2 (no)
JP (1) JP2005528418A (no)
KR (1) KR20050007476A (no)
CN (1) CN1652822A (no)
AU (1) AU2003227710A1 (no)
BR (1) BR0309808A (no)
CA (1) CA2484272A1 (no)
EA (1) EA200401454A1 (no)
HR (1) HRP20041160A2 (no)
IL (1) IL164755A0 (no)
MX (1) MXPA04011018A (no)
NO (1) NO20045343L (no)
PL (1) PL373287A1 (no)
RS (1) RS95304A (no)
WO (1) WO2003094967A2 (no)
ZA (1) ZA200407896B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002342917A1 (en) * 2001-11-19 2003-06-10 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
CA2569833A1 (en) * 2004-04-30 2005-11-10 Altana Pharma Ag Method of classifying gerd
US20080050428A1 (en) * 2004-10-05 2008-02-28 Altana Pharma Ag Oral Pharmaceutical Preparation Comprising a Proton Pump Antagonist and a Basic Excipient
NZ746603A (en) 2010-11-16 2020-05-29 Texas Heart Inst Agonists that enhance binding of integrin-expressing cells to integrin receptors
KR101873530B1 (ko) * 2012-04-10 2018-07-02 삼성전자주식회사 모바일 기기, 모바일 기기의 입력 처리 방법, 및 모바일 기기를 이용한 전자 결제 방법
JO3737B1 (ar) * 2015-07-21 2021-01-31 Athenex Therapeutics Ltd تركيبات علاجية من باكليتاكسيل تعطى عن طريق الفم ومثبط P-gp لعلاج السرطان

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
ES2176252T3 (es) * 1993-07-02 2002-12-01 Altana Pharma Ag Benzamidas sustituidas con fluoro-alcoxi y su utilizacion como agentes inhibidores de fosfodiesterasas de nucleotidos ciclicos.
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
CA2211646C (en) * 1995-01-27 2008-09-09 Rhone Poulenc Rorer Limited Substituted phenyl compounds as endothelin antagonists
DE69635048T2 (de) * 1995-06-12 2006-02-16 G.D. Searle & Co. Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
CA2228953A1 (en) * 1995-09-26 1997-04-03 Takeda Chemical Industries, Ltd. Phosphorylamides, their preparation and use
SE9603725D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New teatment
US6380222B2 (en) * 1996-10-11 2002-04-30 Astrazeneca Ab Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP1003554B1 (en) * 1997-07-25 2004-11-03 ALTANA Pharma AG Proton pump inhibitor in therapeutic combination with antibacterial substances
US6060472A (en) * 1998-04-06 2000-05-09 Apotex Inc. Thiadiazole compounds useful as inhibitors of H+ /K+ atpase
IL141335A0 (en) * 1998-08-26 2002-03-10 Smithkline Beecham Corp Therapies for treating pulmonary diseases
HUP0102990A3 (en) * 1998-09-23 2002-09-30 Altana Pharma Ag Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
GB9911017D0 (en) * 1999-05-13 1999-07-14 Zeneca Ltd Pharmaceutical compositions
ATE311389T1 (de) * 2000-03-29 2005-12-15 Altana Pharma Ag Wirkstoffvorläufer von imidazopyridin-derivaten
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
AU2002227123A1 (en) * 2000-11-07 2002-05-21 Merck And Co., Inc. Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist
AU2002342917A1 (en) * 2001-11-19 2003-06-10 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders

Also Published As

Publication number Publication date
CN1652822A (zh) 2005-08-10
RS95304A (en) 2006-12-15
AU2003227710A1 (en) 2003-11-11
EP1506016A2 (en) 2005-02-16
EA200401454A1 (ru) 2005-06-30
BR0309808A (pt) 2005-03-01
WO2003094967A3 (en) 2004-04-01
HRP20041160A2 (en) 2005-08-31
NO20045343L (no) 2004-12-06
ZA200407896B (en) 2006-06-28
PL373287A1 (en) 2005-08-22
US20050222193A1 (en) 2005-10-06
JP2005528418A (ja) 2005-09-22
CA2484272A1 (en) 2003-11-20
MXPA04011018A (es) 2005-01-25
WO2003094967A2 (en) 2003-11-20
KR20050007476A (ko) 2005-01-18

Similar Documents

Publication Publication Date Title
GB0218625D0 (en) Pharmaceutical compounds
PL360967A1 (en) Pharmaceutical compound containing donepezyl hydrochloride
AU2003291103A8 (en) Pharmaceutical composition
AU2003276549A8 (en) Pharmaceutical compositions containing a biguanide-glitazone combination
IL164547A0 (en) Pharmaceutical composition
IL158083A0 (en) A PHARMACEUTICAL COMPOSITION CONTAINING AN Eg5 PROTEIN INHIBITOR
AU2003250372A8 (en) Pharmaceutical composition
GB0215775D0 (en) Pharmaceutical compounds
GB0220448D0 (en) Fluid dispenser
EP1541139A4 (en) DRUG COMPOSITION WITH NF-KAPPA B HEMMER
IL164755A0 (en) Pharmaceutical composition containing a reversibleprotein pump inhibitor
GB0227173D0 (en) Dispensing pump
GB0206343D0 (en) Fluid dispenser
AU2003291642A8 (en) Pyrazoloazepine compounds as pharmaceutical agents
HK1065477A1 (en) Pharmaceutical composition
AU2003208621A1 (en) A pharmaceutical composition
AU2003283218A8 (en) Fluid dispenser
GB0204392D0 (en) Pharmaceutical compound
IL164756A0 (en) Pharmaceutical compositions containing protein pump inhibitors
HU0200337D0 (en) Stabilised pharmaceutical composition
HU0300070V0 (en) Fluid dispenser
GB0217703D0 (en) Pharmaceutical composition
GB0212462D0 (en) Pharmaceutical compound
GB0204391D0 (en) Pharmaceutical compound
GB0212459D0 (en) Pharmaceutical compound